Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women
Author(s) -
Paul Natureeba,
Abel Kakuru,
Mary Muhindo,
Teddy Ochieng,
John Ategeka,
Catherine A. Koss,
Albert Plenty,
Edwin D. Charlebois,
Tamara D. Clark,
Bridget Nzarubara,
Miriam Nakalembe,
Deborah Cohan,
Gabrielle Rizzuto,
Atis Muehlenbachs,
Theodore Ruel,
Prasanna Jagannathan,
Diane V. Havlir,
Moses R. Kamya,
Grant Dorsey
Publication year - 2017
Publication title -
the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jix110
Subject(s) - medicine , malaria , relative risk , obstetrics , dihydroartemisinin , pregnancy , confidence interval , plasmodium falciparum , immunology , artemisinin , biology , genetics
Daily trimethoprim-sulfamethoxazole (TMP-SMX) and insecticide-treated nets remain the main interventions for prevention of malaria in human immunodeficiency virus (HIV)-infected pregnant women in Africa. However, antifolate and pyrethroid resistance threaten the effectiveness of these interventions, and new ones are needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom